Recombinant gene engineering production, E. coli expression.

Human epidermal growth factor (hEGF) is a small protein composed of 53 amino acids, with three pairs of disulfide bonds, making it relatively stable to physical and chemical factors such as acid, base, and heat. hEGF has a wide range of biological effects, strongly promoting the growth of various epidermal tissues, and has been used in medical treatment for burn and scald injuries, ulcers, various types of trauma, and corneal damage. hEGF also promotes normal epidermal cell metabolism and, when added to cell culture, can promote cell growth.

• Product source: E.coli
• Product appearance: white or off-white powder
• Specific activity: ≥1*107units/mg
• Purity (HPLC): ≥94%
• Bacterial endotoxin: ≤10EU/mg
• Microbial limits: ≤300cfu/mg

• Good stability: conventional storage at ≤-20°C for one year results in little loss of activity, and after thawing, under aseptic conditions (2-8°C), there is little loss of activity for one month.
• Animal-free: produced by recombination, free of exogenous viral contamination, and no animal-derived raw materials are used in the production process.
• Quality stability: batch production ensures continuous, stable batch production; no batch-to-batch differences and stable quality.
• High purity: high specific activity; low residual host protein below the limit for biologics.
• Complies with regulatory requirements: production equipment and environment comply with relevant regulations, and the production process fully complies with GMP guidelines.

FGF2, IGF-1, LR3, Transferrin, Noggin